Vertical margin distance in T1 colorectal carcinoma resected by endoscopic submucosal dissection affects prognosis after additional surgery.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
16 Aug 2024
Historique:
accepted: 25 07 2024
medline: 16 8 2024
pubmed: 16 8 2024
entrez: 16 8 2024
Statut: epublish

Résumé

PURPOSE : A vertical margin (VM) distance of < 500 µm is a risk factor for recurrence in patients with T1 colorectal carcinoma (CRC) resected by endoscopy. We aimed to determine the effects of the VM distance on the recurrence and prognosis of T1 CRC. We enrolled 168 patients with T1 CRC who underwent additional surgery after endoscopic submucosal dissection (ESD) at multiple centers between 2008 and 2016. None of the patients were followed up for < 5 years. The enrolled 168 patients were classified into patients with VM distance of < 500 µm including positive VM (n = 72 [43%], VM distance < 500 µm group) and patients with VM distance of ≥ 500 µm (n = 96 [57%], VM distance ≥ 500 µm group). The clinicopathological features, recurrence rates, and prognoses were compared between the groups using propensity-score matching (PSM). Tumors recurred in eight of the 168 patients (5%) with VM distance < 500 µm. After PSM, the rate of overall recurrence and local recurrence in the VM distance < 500 µm group were significantly higher than those in the VM distance ≥ 500 µm group. The 5-year recurrence-free survival rate was significantly higher in the VM distance ≥ 500 µm group than that in VM distance < 500 µm group after PSM (100% vs. 89%, p < 0.012). Complete en bloc resection of T1 CRC via ESD must include a sufficient amount of SM to reduce the risk of metastasis and recurrence after additional surgery.

Identifiants

pubmed: 39150588
doi: 10.1007/s00384-024-04700-0
pii: 10.1007/s00384-024-04700-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

134

Informations de copyright

© 2024. The Author(s).

Références

Hori M, Matsuda T, Shibata A et al (2015) Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 45:884–891. https://doi.org/10.1093/jjco/hyv088
doi: 10.1093/jjco/hyv088 pubmed: 26142437
Morson BC, Whiteway JE, Jones EA, Macrae FA, Williams CB (1984) Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut 25:437–444. https://doi.org/10.1136/gut.25.5.437
doi: 10.1136/gut.25.5.437 pubmed: 6714785 pmcid: 1432448
Hashiguchi Y, Muro K, Saito Y et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1–42. https://doi.org/10.1007/s10147-019-01485-z
doi: 10.1007/s10147-019-01485-z pubmed: 31203527
Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 127:385–394. https://doi.org/10.1053/j.gastro.2004.04.022
doi: 10.1053/j.gastro.2004.04.022 pubmed: 15300569
Bosch SL, Teerenstra S, de Wilt JH, Cunningham C, Nagtegaal ID (2013) Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy 45:827–834. https://doi.org/10.1055/s-0033-1344238
doi: 10.1055/s-0033-1344238 pubmed: 23884793
Wada H, Shiozawa M, Katayama K et al (2015) Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer. J Gastroenterol 50:727–734. https://doi.org/10.1007/s00535-015-1057-0
doi: 10.1007/s00535-015-1057-0 pubmed: 25725617
Ikematsu H, Yoda Y, Matsuda T et al (2013) Long-term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterology 144:551–559. https://doi.org/10.1053/j.gastro.2012.12.003
doi: 10.1053/j.gastro.2012.12.003 pubmed: 23232297
Yoda Y, Ikematsu H, Matsuda T et al (2013) A large-scale multicenter study of long-term outcomes after endoscopic resection for submucosal invasive colorectal cancer. Endoscopy 45:718–724. https://doi.org/10.1055/s-0033-1344234
doi: 10.1055/s-0033-1344234 pubmed: 23918621
Yasue C, Chino A, Takamatsu M et al (2019) Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions. J Gastroenterol 54:708–717. https://doi.org/10.1007/s00535-019-01564-y
doi: 10.1007/s00535-019-01564-y pubmed: 30810812
Urabe Y, Tanaka S, Saito Y et al (2015) Impact of revisions of the JSCCR guidelines on the treatment of T1 colorectal carcinomas in Japan. Z Gastroenterol 53:291–301. https://doi.org/10.1055/s-0034-1385764
doi: 10.1055/s-0034-1385764 pubmed: 25860579
Asayama N, Oka S, Tanaka S et al (2015) Endoscopic submucosal dissection as total excisional biopsy for clinical T1 colorectal carcinoma. Digestion 91:64–69. https://doi.org/10.1159/000368866
doi: 10.1159/000368866 pubmed: 25632920
Ozawa S, Tanaka S, Hayashi N et al (2013) Risk factors for vertical incomplete resection in endoscopic submucosal dissection as total excisional biopsy for submucosal invasive colorectal carcinoma. Int J Colorectal Dis 28:1247–1256. https://doi.org/10.1007/s00384-013-1701-1
doi: 10.1007/s00384-013-1701-1 pubmed: 23619616
Oka S, Tanaka S, Saito Y et al (2015) Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am J Gastroenterol 110:697–707. https://doi.org/10.1038/ajg.2015.96
doi: 10.1038/ajg.2015.96 pubmed: 25848926
Nishimura T, Oka S, Kamigaichi Y et al (2022) Vertical tumor margin of endoscopic resection for T1 colorectal carcinoma affects the prognosis of patients undergoing additional surgery. Surg Endosc 36:5970–5978. https://doi.org/10.1007/s00464-021-08977-y
doi: 10.1007/s00464-021-08977-y pubmed: 35020058
Nakadoi K, Oka S, Tanaka S et al (2014) Condition of muscularis mucosae is a risk factor for lymph node metastasis in T1 colorectal carcinoma. Surg Endosc 28:1269–1276. https://doi.org/10.1007/s00464-013-3321-9
doi: 10.1007/s00464-013-3321-9 pubmed: 24281433
Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC (2002) Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132. https://doi.org/10.1046/j.1365-2559.2002.01324.x
doi: 10.1046/j.1365-2559.2002.01324.x pubmed: 11952856
Kawachi H, Eishi Y, Ueno H et al (2015) A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study. Mod Pathol 28:872–879. https://doi.org/10.1038/modpathol.2015.36
doi: 10.1038/modpathol.2015.36 pubmed: 25720321
Kitajima K, Fujimori T, Fujii S et al (2004) Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol 39:534–543. https://doi.org/10.1007/s00535-004-1339-4
doi: 10.1007/s00535-004-1339-4 pubmed: 15235870
Ichimasa K, Kudo SE, Miyachi H et al (2017) Patient gender as a factor associated with lymph node metastasis in T1 colorectal cancer: a systematic review and meta-analysis. Mol Clin Oncol 6:517–524. https://doi.org/10.3892/mco.2017.1172
doi: 10.3892/mco.2017.1172 pubmed: 28413659 pmcid: 5374909
Naito A, Iwamoto K, Ohtsuka M et al (2021) Risk factors for lymph node metastasis in pathological T1b colorectal cancer. In Vivo 35:987–991. https://doi.org/10.21873/invivo.12341
doi: 10.21873/invivo.12341 pubmed: 33622893 pmcid: 8045107
Belderbos TD, van Erning FN, de Hingh IH et al (2017) Long-term recurrence-free survival after standard endoscopic resection versus surgical resection of submucosal invasive colorectal cancer: a population-based study. Clin Gastroenterol Hepatol 15:403-411.e1. https://doi.org/10.1016/j.cgh.2016.08.041
doi: 10.1016/j.cgh.2016.08.041 pubmed: 27609703
Rickert A, Aliyev R, Belle S et al (2014) Oncologic colorectal resection after endoscopic treatment of malignant polyps: does endoscopy have an adverse effect on oncologic and surgical outcomes? Gastrointest Endosc 79:951–960. https://doi.org/10.1016/j.gie.2013.11.014
doi: 10.1016/j.gie.2013.11.014 pubmed: 24412574
Asayama N, Oka S, Tanaka S et al (2016) Long-term outcomes after treatment for T1 colorectal carcinoma. Int J Colorectal Dis 31:571–578. https://doi.org/10.1007/s00384-015-2473-6
doi: 10.1007/s00384-015-2473-6 pubmed: 26689400
Choi DH, Sohn DK, Chang HJ et al (2009) Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas: a prospective cohort study. Dis Colon Rectum 52:438–445. https://doi.org/10.1007/DCR.0b013e318197e37f
doi: 10.1007/DCR.0b013e318197e37f pubmed: 19333043
Tamaru Y, Oka S, Tanaka S et al (2017) Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group. J Gastroenterol 52:1169–1179. https://doi.org/10.1007/s00535-017-1318-1
doi: 10.1007/s00535-017-1318-1 pubmed: 28194526
Yoshii S, Nojima M, Nosho K et al (2014) Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors. Clin Gastroenterol Hepatol 12:292-302.e3. https://doi.org/10.1016/j.cgh.2013.08.008
doi: 10.1016/j.cgh.2013.08.008 pubmed: 23962552
Yasue C, Chino A, Ishioka M et al (2022) Risk factors for vertical incomplete resection in endoscopic submucosal dissection of deep invasive submucosal colorectal cancer. Scand J Gastroenterol 57:1011–1017. https://doi.org/10.1080/00365521.2022.2053738
doi: 10.1080/00365521.2022.2053738 pubmed: 35311597
Kunihiro M, Tanaka S, Haruma K et al (2000) Electrocautery snare resection stimulates cellular proliferation of residual colorectal tumor: an increasing gene expression related to tumor growth. Dis Colon Rectum 43:1107–1115. https://doi.org/10.1007/BF02236558
doi: 10.1007/BF02236558 pubmed: 10950009
Yamashita K, Oka S, Tanaka S et al (2019) Preceding endoscopic submucosal dissection for T1 colorectal carcinoma does not affect the prognosis of patients who underwent additional surgery: a large multicenter propensity score-matched analysis. J Gastroenterol 54:897–906. https://doi.org/10.1007/s00535-019-01590-w
doi: 10.1007/s00535-019-01590-w pubmed: 31104172
Yamashita K, Oka S, Tanaka S et al (2019) Long-term prognosis after treatment for T1 carcinoma of laterally spreading tumors: a multicenter retrospective study. Int J Colorectal Dis 34:481–490. https://doi.org/10.1007/s00384-018-3203-7
doi: 10.1007/s00384-018-3203-7 pubmed: 30607579
Nishimura T, Oka S, Tanaka S et al (2021) Clinical significance of immunohistochemical lymphovascular evaluation to determine additional surgery after endoscopic submucosal dissection for colorectal T1 carcinoma. Int J Colorectal Dis 36:949–958. https://doi.org/10.1007/s00384-020-03795-5
doi: 10.1007/s00384-020-03795-5 pubmed: 33150491
Yamaoka Y, Imai K, Shiomi A et al (2020) Endoscopic resection of T1 colorectal cancer prior to surgery does not affect surgical adverse events and recurrence. Surg Endosc 34:5006–5016. https://doi.org/10.1007/s00464-019-07295-8
doi: 10.1007/s00464-019-07295-8 pubmed: 31820150
Takamaru H, Saito Y, Sekiguchi M et al (2021) Endoscopic resection before surgery does not affect the recurrence rate in patients with high-risk T1 colorectal cancer. Clin Transl Gastroenterol 12:e00336. https://doi.org/10.14309/ctg.0000000000000336
doi: 10.14309/ctg.0000000000000336 pubmed: 33843782 pmcid: 8043730
Kouno H, Tsuruta O, Hasegawa S (2009) Pathological diagnostic issue concerning the vertical margin of submucosal cancer in the colon and rectum. Stomach Intestine 44:1255–1262
Inoue T, Fujii H, Koyama F et al (2016) Intraluminal lavage to remove exfoliated tumor cells after colorectal endoscopic submucosal dissection. Surg Endosc 30:2773–2778. https://doi.org/10.1007/s00464-015-4550-x
doi: 10.1007/s00464-015-4550-x pubmed: 26487195
Tajika M, Niwa Y, Bhatia V et al (2012) A first report of tumor cell implantation after EMR in a patient with rectosigmoid cancer. Gastrointest Endosc 75:1117–1118. https://doi.org/10.1016/j.gie.2011.05.028
doi: 10.1016/j.gie.2011.05.028 pubmed: 21762905
Leijssen LGJ, Dinaux AM, Kinutake H, Bordeianou LG, Berger DL (2019) Do stage I colorectal cancers with lymphatic invasion require a different postoperative approach? J Gastrointest Surg 23:1884–1892. https://doi.org/10.1007/s11605-018-4054-9
doi: 10.1007/s11605-018-4054-9 pubmed: 30511134
Iida S, Hasegawa H, Okabayashi K et al (2012) Risk factors for postoperative recurrence in patients with pathologically T1 colorectal cancer. World J Surg 36:424–430. https://doi.org/10.1007/s00268-011-1378-y
doi: 10.1007/s00268-011-1378-y pubmed: 22187130
Lee JH, Lee JL, Park IJ et al (2017) Identification of recurrence-predictive indicators in stage I colorectal cancer. World J Surg 41:1126–1133. https://doi.org/10.1007/s00268-016-3833-2
doi: 10.1007/s00268-016-3833-2 pubmed: 27872975
Fukui Y, Hida K, Hoshino N et al (2022) Identification of high-risk stage I colon and rectal cancer patients: a retrospective analysis of a large Japanese cohort. Int J Colorectal Dis 37:1403–1410. https://doi.org/10.1007/s00384-022-04161-3
doi: 10.1007/s00384-022-04161-3 pubmed: 35588331
Teloken PE, Ransom D, Faragher I et al (2016) Recurrence in patients with stage I colorectal cancer. ANZ J Surg 86:49–53. https://doi.org/10.1111/ans.13254
doi: 10.1111/ans.13254 pubmed: 26235683
Kajiwara Y, Oka S, Tanaka S et al (2023) Nomogram as a novel predictive tool for lymph node metastasis in T1 colorectal cancer treated with endoscopic resection: a nationwide, multicenter study. Gastrointest Endosc 97:1119-1128.e5. https://doi.org/10.1016/j.gie.2023.01.022
doi: 10.1016/j.gie.2023.01.022 pubmed: 36669574
Ichimasa K, Kudo SE, Mori Y et al (2018) Artificial intelligence may help in predicting the need for additional surgery after endoscopic resection of T1 colorectal cancer. Endoscopy 50:230–240. https://doi.org/10.1055/s-0043-122385
doi: 10.1055/s-0043-122385 pubmed: 29272905
Guo K, Feng Y, Yuan L et al (2020) Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer. Cancer Med 9:5095–5113. https://doi.org/10.1002/cam4.3114
doi: 10.1002/cam4.3114 pubmed: 32469151 pmcid: 7367623
Kamigaichi Y, Oka S, Tanino F et al (2022) Novel endoscopic ultrasonography classification for assured vertical resection margin (≥500 μm) in colorectal endoscopic submucosal dissection. J Gastroenterol Hepatol 37:2289–2296. https://doi.org/10.1111/jgh.16008
doi: 10.1111/jgh.16008 pubmed: 36181255

Auteurs

Fumiaki Tanino (F)

Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan.

Ken Yamashita (K)

Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan. kenyama5@hiroshima-u.ac.jp.

Shinji Nagata (S)

Department of Gastroenterology, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima, Japan.

Toshio Kuwai (T)

Department of Endoscopy, National Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan.

Yuki Kamigaichi (Y)

Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan.

Hidenori Tanaka (H)

Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan.

Yuzuru Tamaru (Y)

Department of Endoscopy, National Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan.

Hidehiko Takigawa (H)

Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan.

Naoki Asayama (N)

Department of Gastroenterology, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima, Japan.

Yuji Urabe (Y)

Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan.

Fumio Shimamoto (F)

Department of Health Sciences, Hiroshima Cosmopolitan University, Hiroshima, Japan.

Shiro Oka (S)

Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH